Thyroid Cancer Treatment Varies by Physician & Environment with Dr. Toro-Tobon

We are honored to have Dr. David Toro-Tobon present "Treatment Aggressiveness for Differentiated Thyroid Cancers Varies Widely and is Influenced by Physician's Attitude and Local Practice Environment." Dr. Max Schumm joins as the featured expert discussant. 0:00 Webinar 2:00 Study Background by Dr. Toro Tobon Dr. Toro Tobon provides background on Dr. Schumm's study. Of 348 ATA respondents, 92.9% agree with the 2015 ATA guidelines. Disagreements arise from regional differences, primary specialty, and lack of high-quality evidence. In DTC, low and intermediate-risk diagnoses lead to varying treatments influenced by surgeon’s training, comorbidities, and physician attitude. 10:00 Physician Perceptions on DTC Risk Dr. Toro Tobon discusses assessing physician perceptions of DTC progression or recurrence risk and its impact on treatment. Physicians consider options like observation, thyroid lobectomy, or total thyroidectomy. Agreement on treatment never exceeds 70%. Those perceiving higher risk reduction with aggressive therapy are 15.1% more likely to choose it; operative risk perception doesn't affect choices. 23:27 Dr. Schumm presents 31:00 Key Findings from Dr. Schumm's Study Dr. Schumm highlights a key finding: Risk and benefit statistics reported to patients don't match the physician’s treatment choices. Local practice patterns (conservative vs. aggressive) significantly influence physician decisions. ** Check out our other programs! ** The THANC Guide https://thancguide.org/ TIRO: Thyroid Int'l Recommendations Online https://tiro.expert/ ** Follow us on Twitter! ** @thancfoundation - https://shorturl.at/puwS0 THANC on FB - https://shorturl.at/svNY4